7Baggers
 Precipio (NASDAQ:PRPO) Rating Lowered to “Hold” at Wall Street Zen  Defense World Sat, 15 Nov 2025 08:12:29 GMT
 Precipio Announces its Q3-2025 Financial Results  The Manila Times Fri, 14 Nov 2025 21:41:33 GMT
 Precipio, Inc. SEC 10-Q Report  TradingView Fri, 14 Nov 2025 21:37:29 GMT
 (PRPO) and the Role of Price-Sensitive Allocations  news.stocktradersdaily.com Tue, 11 Nov 2025 04:38:02 GMT
 Precipio Shares Approach Critical Juncture Ahead of Earnings  AD HOC NEWS Sun, 09 Nov 2025 06:22:04 GMT
 Precipio, Inc Announces Q3-2025 Shareholder Update Call  TradingView Thu, 06 Nov 2025 21:05:00 GMT
 why precipio inc. stock remains on buy lists - cpi data & weekly momentum stock picks  Fundação Cultural do Pará Thu, 06 Nov 2025 11:10:39 GMT
 Precipio Announces Q3-2025 Shareholder Update Call  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 precipio, inc. to host q3-2025 corporate update call on november 17th, 2025  Quiver Quantitative Tue, 04 Nov 2025 22:11:00 GMT
 Precipio Announces Q3-2025 Shareholder Update Call  GlobeNewswire Tue, 04 Nov 2025 22:00:00 GMT
 published on: 2025-11-01 08:42:18  newser.com Sat, 01 Nov 2025 13:42:18 GMT
 international business times  FinancialContent Mon, 27 Oct 2025 19:27:55 GMT

Precipio, Inc
(NASDAQ:PRPO) 

PRPO stock logo

Precipio, Inc., a cancer diagnostics and reagent technology company, provides diagnostic products and services in the United States oncology market. Its product consists of clinical diagnostic services. The company's clinical diagnostic services focus on the diagnosis of different hematopoietic or b...

Founded: 1997
Full Time Employees: 50
Sector: Healthcare
Industry: Diagnostics & Research

Share this website to your friends